zoledronic acid teva generics
teva generics b.v - acidul zoledronic monohidrat - osteoporosis; osteitis deformans - bifosfonatii - tratamentul osteoporosisin post-menopauză femei adulte menat risc crescut de fracturi, inclusiv a celor cu nivel scăzut recent-traumatisme, fractură de șold. tratamentul osteoporozei asociate cu termen lung sistemic glucocorticoizi therapyin post-menopauză femei adulte menat risc crescut de fracturi. tratamentul de boala paget osoase la adulți.
doxiproct 40 mg+20 mg/g
om pharma s.a. - portugalia - combinatii - unguent rectal - 40mg+20mg/g - antihemoroidale topice preparate continind anestezice locale
doxiproct plus 40 mg+20 mg+0,25 mg/g
om pharma s.a. - portugalia - combinatii - unguent rectal - 40mg+20mg+0,25mg/g - antihemoroidale pentru utilizare locala preparate continind corticosteroizi
caelyx pegylated liposomal 2 mg/ml concentrat pentru soluţie perfuzabilă
janssen pharmaceutica nv - doxorubicinum - concentrat pentru soluţie perfuzabilă - 2 mg/ml
erbitux 5 mg/ml soluţie perfuzabilă
merck europe b.v. - cetuximabum - soluţie perfuzabilă - 5 mg/ml
erbitux 5 mg/ml soluţie perfuzabilă
merck europe b.v. - cetuximabum - soluţie perfuzabilă - 5 mg/ml
doxiproct 40 mg+20 mg/g
flavine pharma france - franta - combinatii (calcii dobesilas+lidocainum) - unguent rectal - 40mg+20mg/g - antihemoroidale topice preparate continind anestezice locale
doxiproct plus 40 mg+20 mg+0,25 mg/g
flavine pharma france - franta - combinatii (calcii dobesilas+lidocainum+dexamethasonum) - unguent rectal - 40mg+20mg+0,25mg/g - antihemoroidale pentru utilizare locala preparate continind corticosteroizi
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanomul - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - psoriazis - imunosupresoare - treatment of moderate-to-severe plaque psoriasis in adults.